45. 来自英国一家小型地区综合医院的真实世界SCS结果：这在社会结果和药物影响的背景下真正意味着什么？

IF 3.2 3区医学 Q2 CLINICAL NEUROLOGY

Neuromodulation Pub Date : 2025-06-01 DOI:10.1016/j.neurom.2025.03.047

K. Fleming, J. Thomas, J. Graterol, N. Roberts, A. Doyle

引用次数: 0

摘要

本文章由计算机程序翻译，如有差异，请以英文原文为准。

查看原文本刊更多论文

45. Real world SCS outcome from a small district general hospital in the UK: what does this really mean in the context of social outcomes and pharmaceutical impact?

求助全文

通过发布文献求助，成功后即可免费获取论文全文。去求助

来源期刊

Neuromodulation 医学-临床神经学

CiteScore

6.40

自引率

3.60%

发文量

978

审稿时长

54 days

期刊介绍： Neuromodulation: Technology at the Neural Interface is the preeminent journal in the area of neuromodulation, providing our readership with the state of the art clinical, translational, and basic science research in the field. For clinicians, engineers, scientists and members of the biotechnology industry alike, Neuromodulation provides timely and rigorously peer-reviewed articles on the technology, science, and clinical application of devices that interface with the nervous system to treat disease and improve function.